Emphasis on etanercept

Waikoloa, Hawaii - Phase III trials show etanercept (Enbrel, Amgen Inc. and Wyeth) has efficacy and safety for moderate to severe psoriasis.

Related Videos
Related Content

The Mainstream Patient: February 7

February 7th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

The Art of Smelling Good

February 7th 2023

The Cutaneous Connection: An Inside Look of the Inclusive Atlas

November 4th 2021

The Weekly Roundup: January 30-February 3

February 3rd 2023

Losing a Malpractice Case May Depend on Where You Live

February 3rd 2023

The Mainstream Patient: February 7

February 7th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

The Art of Smelling Good

February 7th 2023

The Cutaneous Connection: An Inside Look of the Inclusive Atlas

November 4th 2021

The Weekly Roundup: January 30-February 3

February 3rd 2023

Losing a Malpractice Case May Depend on Where You Live

February 3rd 2023

The Mainstream Patient: February 7

February 7th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

The Art of Smelling Good

February 7th 2023

The Cutaneous Connection: An Inside Look of the Inclusive Atlas

November 4th 2021

The Weekly Roundup: January 30-February 3

February 3rd 2023

Losing a Malpractice Case May Depend on Where You Live

February 3rd 2023
Advertise
Contact Us
Job Board
Do Not Sell My Information
Terms and Conditions
Privacy Policy
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.